Valrubicin

In the US, Valrubicin (valrubicin systemic) is a member of the drug class antibiotics/antineoplastics and is used to treat Urinary Tract Tumors.

US matches:

• Valrubicin


• Valrubicin Intravesical

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01DB09

CAS registry number (Chemical Abstracts Service)

0056124-62-0

Chemical Formula

C34-H36-F3-N-O13

Molecular Weight

723

Therapeutic Category

Antineoplastic antibacterial

Chemical Name

(8S, 10S)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione 8²-valerate (WHO)

Foreign Names

• Valrubicinum (Latin)
• Valrubicin (German)
• Valrubicine (French)
• Valrubicina (Spanish)

Generic Names

• Valrubicin (OS: USAN)
• AD 32 (IS)
• NSC 246131 (IS)
• Valrubicin (PH: USP 32)

Brand Names

• Valstar
  Celltech, United States; Endo, United States; Medison, Israel

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.